{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:30:34Z","timestamp":1649028634624},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.1097\/qai.0b013e318224d0c7","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T15:22:02Z","timestamp":1307114522000},"page":"1-8","source":"Crossref","is-referenced-by-count":2,"title":["Augmented HIV-Specific Interferon-Gamma Responses, But Impaired Lymphoproliferation During Interruption of Antiretroviral Treatment Initiated in Primary HIV Infection"],"prefix":"10.1097","volume":"58","author":[{"given":"Elizabeth","family":"Connick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenia","family":"Aga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Schlichtemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M","family":"Demeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Volberding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210131","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-122-8-199504150-00003","article-title":"Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.","volume":"122","author":"Mellors","year":"1995","journal-title":"Ann Intern Med"},{"key":"R2-1-20210131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bmj.299.6692.154","article-title":"Clinical course of primary HIV infection: consequences for subsequent course of infection.","volume":"299","author":"Pedersen","year":"1989","journal-title":"BMJ"},{"key":"R3-1-20210131","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-128-8-199804150-00001","article-title":"Biological and virologic characteristics of primary HIV infection.","volume":"128","author":"Schacker","year":"1998","journal-title":"Ann Intern Med"},{"key":"R4-1-20210131","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection.","volume":"407","author":"Rosenberg","year":"2000","journal-title":"Nature"},{"key":"R5-1-20210131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.193.2.169","article-title":"Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.","volume":"193","author":"Altfeld","year":"2001","journal-title":"J Exp Med"},{"key":"R6-1-20210131","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","article-title":"CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.","volume":"68","author":"Matloubian","year":"1994","journal-title":"J Virol"},{"key":"R7-1-20210131","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0b013e32832eb285","article-title":"Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.","volume":"23","author":"Volberding","year":"2009","journal-title":"AIDS"},{"key":"R8-1-20210131","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CDLI.7.5.759-763.2000","article-title":"Shipment impairs lymphocyte proliferative responses to microbial antigens.","volume":"7","author":"Betensky","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"R9-1-20210131","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","article-title":"Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.","volume":"178","author":"Lederman","year":"1998","journal-title":"J Infect Dis"},{"key":"R10-1-20210131","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1128\/CVI.00479-07","article-title":"In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits.","volume":"15","author":"Weinberg","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R11-1-20210131","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1128\/JVI.76.12.5925-5936.2002","article-title":"Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.","volume":"76","author":"Palmer","year":"2002","journal-title":"J Virol"},{"key":"R12-1-20210131","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"R13-1-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","article-title":"Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.","volume":"322","author":"Bull","year":"2007","journal-title":"J Immunol Methods"},{"key":"R14-1-20210131","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1371\/journal.pmed.0010036","article-title":"Limited durability of viral control following treated acute HIV infection.","volume":"1","author":"Kaufmann","year":"2004","journal-title":"PLoS Med"},{"key":"R15-1-20210131","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1089\/aid.2007.0047","article-title":"Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study.","volume":"23","author":"Goujard","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R16-1-20210131","first-page":"83","article-title":"Potential role of immune modulation in the effective long-term control of HIV-1 infection.","volume":"16","author":"Rizzardi","year":"2002","journal-title":"J Biol Regul Homeost Agents"},{"key":"R17-1-20210131","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/506364","article-title":"Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.","volume":"194","author":"Jacobson","year":"2006","journal-title":"J Infect Dis"},{"key":"R18-1-20210131","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/00126334-200407010-00005","article-title":"Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400\/mm3.","volume":"36","author":"Plana","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-1-20210131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells.","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"R20-1-20210131","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.4049\/jimmunol.175.10.6948","article-title":"Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.","volume":"175","author":"Seth","year":"2005","journal-title":"J Immunol"},{"key":"R21-1-20210131","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/432002","article-title":"Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.","volume":"192","author":"Kinloch-de Loes","year":"2005","journal-title":"J Infect Dis"},{"key":"R22-1-20210131","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JVI.02073-08","article-title":"Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes.","volume":"83","author":"Chen","year":"2009","journal-title":"J Virol"},{"key":"R23-1-20210131","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation.","volume":"330","author":"Pereyra","year":"2010","journal-title":"Science"},{"key":"R24-1-20210131","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1002\/1521-4141(200212)32:12<3756::AID-IMMU3756>3.0.CO;2-E","article-title":"Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.","volume":"32","author":"Ellefsen","year":"2002","journal-title":"Eur J Immunol"},{"key":"R25-1-20210131","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(04)15735-8","article-title":"HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.","volume":"363","author":"Hess","year":"2004","journal-title":"Lancet"},{"key":"R26-1-20210131","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1128\/JVI.02212-07","article-title":"Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.","volume":"82","author":"Daucher","year":"2008","journal-title":"J Virol"},{"key":"R27-1-20210131","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.","volume":"204","author":"Almeida","year":"2007","journal-title":"J Exp Med"},{"key":"R28-1-20210131","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood.V92.9.3105.421k46_3105_3114","article-title":"Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome.","volume":"92","author":"Barker","year":"1998","journal-title":"Blood"},{"key":"R29-1-20210131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.0022-202x.2001.00049.x","article-title":"Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy.","volume":"6","author":"Connick","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R30-1-20210131","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"R31-1-20210131","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1172\/JCI114376","article-title":"Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.","volume":"84","author":"Clerici","year":"1989","journal-title":"J Clin Invest"},{"key":"R32-1-20210131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/172.1.79","article-title":"In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus.","volume":"172","author":"Dolan","year":"1995","journal-title":"J Infect Dis"},{"key":"R33-1-20210131","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment.","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R34-1-20210131","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival.","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"R35-1-20210131","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2009.828","article-title":"Universal voluntary testing and treatment for prevention of HIV transmission.","volume":"301","author":"Dieffenbach","year":"2009","journal-title":"JAMA"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e318224d0c7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:53:43Z","timestamp":1620971623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201109010-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318224d0c7","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}